Department of Social and Preventive Medicine, Sungkyunkwan University School of Medicine, Jangan-gu, Suwon, Korea.
J Korean Med Sci. 2013 Jun;28(6):808-13. doi: 10.3346/jkms.2013.28.6.808. Epub 2013 Jun 3.
This study renewed the estimation of disability weights for cancers in Korea, reflecting the nation's economic and medical-technological development during the past 10 yr. Thirty-two medical doctors evaluated disability weights for 24 major cancers based on the visual analogue scale (VAS) method. To check the intra-rater reliability, a correlation was calculated between 2011 and 2012 medians. To assess the inter-rater reliability, a correlation was estimated between oncologist and non-oncologist medians. To assess the inter-method reliability, a correlation was calculated between medians on VAS and Person-Trade-Off approaches. Moreover, findings in this study were compared to those in 2003 research. Spearman correlation was used and the 1% significance level was applied. Disability weights were relatively high for pancreas cancer (0.90), gallbladder cancer (0.81), mouth and oropharynx cancer (0.80), and esophagus cancer (0.80). Conversely, they were relatively low for breast cancer (0.37), prostate cancer (0.33) and thyroid cancer (0.10). All the inter-rater reliabilities were higher than 0.7. Indeed, the intra-rater and inter-method reliabilities were 0.752 and 0.927, respectively. Above all, disability weights for major cancers went down in Korea during 2003-2012, reflecting the progress of medical technology and the growth of cancer survival.
这项研究更新了韩国癌症残疾权重的估计，反映了过去 10 年来国家经济和医疗技术的发展。32 名医生根据视觉模拟量表（VAS）方法评估了 24 种主要癌症的残疾权重。为了检查内部评分者的可靠性，计算了 2011 年和 2012 年中位数之间的相关性。为了评估评分者间的可靠性，计算了肿瘤学家和非肿瘤学家中位数之间的相关性。为了评估跨方法的可靠性，计算了 VAS 和个人交易法中位数之间的相关性。此外，还将本研究的结果与 2003 年的研究进行了比较。使用 Spearman 相关系数，应用 1%的显著性水平。胰腺癌（0.90）、胆囊癌（0.81）、口腔和口咽癌（0.80）和食管癌（0.80）的残疾权重相对较高。相反，乳腺癌（0.37）、前列腺癌（0.33）和甲状腺癌（0.10）的残疾权重相对较低。所有评分者间的可靠性都高于 0.7。事实上，内部评分者和跨方法的可靠性分别为 0.752 和 0.927。最重要的是，2003-2012 年期间，韩国主要癌症的残疾权重下降，反映了医疗技术的进步和癌症生存率的提高。
